Phase I Study of Proton Radiotherapy and Bevacizumab for Primary Liver Tumors.

Trial Profile

Phase I Study of Proton Radiotherapy and Bevacizumab for Primary Liver Tumors.

Discontinued
Phase of Trial: Phase I

Latest Information Update: 26 Nov 2014

At a glance

  • Drugs Bevacizumab (Primary)
  • Indications Cholangiocarcinoma; Liver cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 17 Dec 2009 Actual patient number (3) added as reported by ClinicalTrials.gov.
    • 17 Dec 2009 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
    • 30 Nov 2009 Actual end date (1 Nov 2009) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top